Page last updated: 2024-11-12

adhyperforin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

adhyperforin: isolated from Hypericum perforatum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
HypericumgenusGenus of perennial plants in the family CLUSIACEAE (sometimes classified as Hypericaceae). Herbal and homeopathic preparations are used for depression, neuralgias, and a variety of other conditions. Hypericum contains flavonoids; GLYCOSIDES; mucilage, TANNINS; volatile oils (OILS, ESSENTIAL), hypericin and hyperforin.[MeSH]Hypericaceae[no description available]

Cross-References

ID SourceID
PubMed CID49797259
CHEMBL ID388948
MeSH IDM0383395

Synonyms (2)

Synonym
adhyperforin
CHEMBL388948
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID290195Cytotoxicity against rat L6 cells after 72 hrs2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
In vitro antimalarial activity of hyperforin, a prenylated acylphloroglucinol. A structure-activity study.
AID290194Antiplasmodial activity after 48 hrs against Plasmodium falciparum K1 in human erythrocytes2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
In vitro antimalarial activity of hyperforin, a prenylated acylphloroglucinol. A structure-activity study.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (77.78)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]